Results

Total Results: 423 records

Showing results for "aspirin".

141. Announcements | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/news/announcements?page=27
     September 30, 2013 - Language Delay and Disorders in Children 2013-07-25 Public Comment on Draft Research Plan: Aspirin … Extension of Opportunity for Public Comment 2013-06-17 Public Comment on Draft Research Plan: Aspirin

142. Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index in Adults: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/jX6LgJPwAUuzYHYoaQ9Mqp
     September 01, 2013 - One randomized trial found that aspirin did not reduce CVD events in patients with a low ABI (2). … One study showed that low-dose aspirin treatment in asymp- tomatic patients with a low ABI may increase … Treatment Evidence shows that low-dose aspirin treatment in asymptomatic patients with a low ABI does … Of those, 3350 were randomly assigned to aspirin therapy (100 mg/d) or placebo. … for Asymptomatic Atherosclerosis, which compared daily aspirin therapy with a placebo control.

143. Screening for Hypertension in Adults: Clinician Summary (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZLDgVoLvb--9ooeW9o5n8f
     April 01, 2021 - cardiovascular risk factors • Statin use for the primary prevention of cardiovascular disease in adults • Aspirin … statin-use-in-adults-preventive-medication https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-and-cancer

144. A and B Recommendations | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-and-b-recommendations
     December 01, 2021 - B December 2019 * Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive … aged 50 to 59 years with a 10% or greater 10-year cvd risk The USPSTF recommends initiating low-dose aspirin … B April 2016 * Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality … Medication: pregnant persons at high risk for preeclampsia The USPSTF recommends the use of low-dose aspirin … See the Practice Considerations section for information on high risk and aspirin dose.

145. Hablémoslo: Comenzar a Tomar Aspirina para Prevenir Enfermedades Cardíacas y Derrames Cerebrales (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/lets-talk-about-it-aspirin-cvd-prevention-spanish.pdf
     December 19, 2022 - Hablémoslo: Comenzar a Tomar Aspirina para Prevenir Enfermedades Cardíacas y Derrames Cerebrales Hablémoslo Comenzar a Tomar Aspirina para Prevenir Enfermedades Cardíacas y Derrames Cerebrales Para pacientes Tomar aspirina de dosis baja, también conocida como “aspirina de bebé”, puede disminuir las posibilidades d…

146. Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/crPsNJ_R5SFnJhuT2CEpkr
     March 01, 2019 - Eligible treatment studies compared warfarin, aspirin, or novel oral anticoagulants (NOACs) with placebo … The BAATAF trial allowed participants in the no treatment group to take aspirin, but use of aspirin or … , 325 mg/d (n = 206) Placebo (n = 211) Group 2d: Aspirin, 325 mg/d (n = 346) Placebo (n = 357) 1.3 2 … by participants taking aspirin. … AFASAK indicates Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation study; BAATAF, Boston

147. New Resource: Notable 2022 Final Recommendations | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/new-resource-notable-2022-final-recommendations
     January 01, 2022 - Anxiety in Children & Adolescents Screening for Depression & Suicide Risk in Children and Adolescents Aspirin

148. Task Force Resources | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/task-force-resources
     May 04, 2025 - that can help reduce breast cancer risk among women who are at high risk Let's Talk About It: Starting Aspirin … facilitate meaningful discussions between healthcare professionals and their patients about whether starting aspirin

149. 2021 Report to Congress on Evidence Gaps | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/2021-report-congress-evidence-gaps
     January 01, 2021 - Topics highlighted in the report include: Cardiovascular Disease Hypertension in Adults: Screening Aspirin

150. Information for Professionals | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/tools-and-resources-for-better-preventive-care
     Pediatric, Adolescent Aspirin Use to Prevent Cardiovascular … Adult, Senior Aspirin to Prevent Cardiovascular Disease

151. Screening for Asymptomatic Carotid Artery Stenosis: Clinical Summary of USPSTF Task Force Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/YMe6Ff-Esj5uaLmsZECM4b
     April 04, 2019 - In addition, the USPSTF recommends the use of aspirin for persons at increased risk for cardiovascular

152. First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/tfannrpt2011.pdf
     January 01, 2012 - Aspirin Use to Prevent Heart Attacks and Strokes in Adults Ages 80 Years and Older The USPSTF will continue … strokes in women and recommended that primary care clinicians discuss aspirin use with middle-aged … A Aspirin to Prevent Ischemic Stroke: Women Ages 55 to 79 Years The USPSTF recommends the use of aspirin … the use of aspirin for myocardial infarction prevention in men younger than age 45 years. … the use of aspirin for stroke prevention in women younger than age 55 years.

153. Recommendation: Cardiovascular Disease: Risk Assessment With Nontraditional Risk Factors | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/cardiovascular-disease-screening-using-nontraditional-risk-assessment
     July 10, 2018 - activity, screening for peripheral artery disease and CVD risk assessment with the ABI, and low-dose aspirin … Two RCTs (total N = 4626) compared using the ABI to guide decisions to start aspirin therapy vs usual … Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. … Fowkes FG, Price JF, Stewart MC, et al; Aspirin for Asymptomatic Atherosclerosis Trialists. … Aspirin Use to Prevent Cardiovascular Disease and Cancer: A Decision Analysis.

154. Shared Decision Making About Screening and Chemoprevention | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/shared-decision-making-about-screening-and-chemoprevention
     January 01, 2017 - with adults at increased risk for coronary heart disease and that adults not take aspirin prophylaxis … The clinician and patient decide to address aspirin chemoprevention at this visit, arranging to return … and determines that the patient is unfamiliar with the rationale and potential risks of aspirin use. … The clinician and patient agree to defer aspirin use for now, but the clinician makes a note to return … Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. 

155. Shared Decision Making About Screening and Chemoprevention | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/shared-decision-making-about-screening-and-chemoprevention
     January 01, 2017 - with adults at increased risk for coronary heart disease and that adults not take aspirin prophylaxis … The clinician and patient decide to address aspirin chemoprevention at this visit, arranging to return … and determines that the patient is unfamiliar with the rationale and potential risks of aspirin use. … The clinician and patient agree to defer aspirin use for now, but the clinician makes a note to return … Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. 

156. Archived: Final Evidence Summary: Peripheral Arterial Disease (PAD) and CVD in Adults: Risk Assessment with Ankle Brachial Index | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary41/peripheral-arterial-disease-pad-and-cvd-in-adults-risk-assessment-with-ankle-brachial-index
     September 03, 2013 - Of 2 treatment trials meeting inclusion criteria, 1 large trial ( n = 3350) showed that low-dose aspirin … Evidence on treatment benefits and harms was limited to aspirin and was scant. … randomly assigned to receive aspirin, 100 mg/d, or placebo. … Persons randomly assigned to aspirin may have had an increased risk (hazard ratio, 1.71 [CI, 0.99 to … Direct trial evidence in asymptomatic persons with low ABI shows that low-dose aspirin probably does

157. The Ankle–Brachial Index for PAD and CVD Prediction Among Asymptomatic Adults: A Systematic Evidence Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/R_Fp-7sDqohFNj_9WF3_tY
     September 01, 2013 - Of 2 treatment trials meeting inclusion criteria, 1 large trial (n � 3350) showed that low-dose aspirin … Evidence on treatment benefits and harms was limited to aspirin and was scant. … randomly assigned to receive aspirin, 100 mg/d, or placebo. … Persons randomly assigned to aspirin may have had an increased risk (hazard ratio, 1.71 [CI, 0.99 to … Direct trial evidence in asymptomatic persons with low ABI shows that low-dose aspirin probably does

158. Archived: Final Evidence Summary: Peripheral Arterial Disease (PAD) and CVD in Adults: Risk Assessment with Ankle Brachial Index | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary41/peripheral-arterial-disease-pad-and-cvd-in-adults-risk-assessment-with-ankle-brachial-index-2013
     September 03, 2013 - Of 2 treatment trials meeting inclusion criteria, 1 large trial ( n = 3350) showed that low-dose aspirin … Evidence on treatment benefits and harms was limited to aspirin and was scant. … randomly assigned to receive aspirin, 100 mg/d, or placebo. … Persons randomly assigned to aspirin may have had an increased risk (hazard ratio, 1.71 [CI, 0.99 to … Direct trial evidence in asymptomatic persons with low ABI shows that low-dose aspirin probably does

159. Clinical Summary: Screening for Atrial Fibrillation With Electrocardiography (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/cPT4VRq6a8QxTtRQXZBtSc
     July 31, 2018 - counseling on smoking cessation, counseling to promote healthful diet and physical activity , and low -dose aspirin

160. Vitamin, Mineral, and Multivitamin Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: Clinical Summary of USPSTF Recommendation (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/Sx33VN5ShN4UWxpEPjSYAd
     February 19, 2014 - screening for lipid disorders, hypertension, diabetes, and cancer; obesity screening and counseling; and aspirin